Latest news
Loading news…
T-Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Cambridgeshire, United Kingdom Founded 2022 51-100 employees For Profit
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- IT spend
- $1M
Company Info
- Founded
- 2022
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 39
- HQ
- Cambridge, Cambridgeshire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.2
- Trend (90d)
- -0.9
- Last leadership hire
- Mar 10, 2025
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to T-Therapeutics
Loading news…
FAQs about T-Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.